INSERM, U740, Paris, F-75010, France.
Brain. 2013 Jun;136(Pt 6):1830-45. doi: 10.1093/brain/awt092. Epub 2013 May 6.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, or CADASIL, one of the most common inherited small vessel diseases of the brain, is characterized by a progressive loss of vascular smooth muscle cells and extracellular matrix accumulation. The disease is caused by highly stereotyped mutations within the extracellular domain of the NOTCH3 receptor (Notch3(ECD)) that result in an odd number of cysteine residues. While CADASIL-associated NOTCH3 mutations differentially affect NOTCH3 receptor function and activity, they all are associated with early accumulation of Notch3(ECD)-containing aggregates in small vessels. We still lack mechanistic explanation to link NOTCH3 mutations with small vessel pathology. Herein, we hypothesized that excess Notch3(ECD) could recruit and sequester functionally important proteins within small vessels of the brain. We performed biochemical, nano-liquid chromatography-tandem mass spectrometry and immunohistochemical analyses, using cerebral and arterial tissue derived from patients with CADASIL and mouse models of CADASIL that exhibit vascular lesions in the end- and early-stage of the disease, respectively. Biochemical fractionation of brain and artery samples demonstrated that mutant Notch3(ECD) accumulates in disulphide cross-linked detergent-insoluble aggregates in mice and patients with CADASIL. Further proteomic and immunohistochemical analyses identified two functionally important extracellular matrix proteins, tissue inhibitor of metalloproteinases 3 (TIMP3) and vitronectin (VTN) that are sequestered into Notch3(ECD)-containing aggregates. Using cultured cells, we show that increased levels or aggregation of Notch3 enhances the formation of Notch3(ECD)-TIMP3 complex, promoting TIMP3 recruitment and accumulation. In turn, TIMP3 promotes complex formation including NOTCH3 and VTN. In vivo, brain vessels from mice and patients with CADASIL exhibit elevated levels of both insoluble cross-linked and soluble TIMP3 species. Moreover, reverse zymography assays show a significant elevation of TIMP3 activity in the brain vessels from mice and patients with CADASIL. Collectively, our findings lend support to a Notch3(ECD) cascade hypothesis in CADASIL disease pathology, which posits that aggregation/accumulation of Notch3(ECD) in the brain vessels is a central event, promoting the abnormal recruitment of functionally important extracellular matrix proteins that may ultimately cause multifactorial toxicity. Specifically, our results suggest a dysregulation of TIMP3 activity, which could contribute to mutant Notch3(ECD) toxicity by impairing extracellular matrix homeostasis in small vessels.
伴有皮质下梗死和白质脑病的脑常染色体显性动脉病,或 CADASIL,是大脑中最常见的遗传性小血管疾病之一,其特征是血管平滑肌细胞的进行性丧失和细胞外基质的积累。该疾病是由 NOTCH3 受体(Notch3(ECD))的细胞外结构域中高度定型的突变引起的,这些突变导致半胱氨酸残基的数量为奇数。虽然 CADASIL 相关的 NOTCH3 突变会导致 NOTCH3 受体功能和活性的差异,但它们都与小血管中 Notch3(ECD) 包含的聚集体的早期积累有关。我们仍然缺乏将 NOTCH3 突变与小血管病理学联系起来的机制解释。在此,我们假设过量的 Notch3(ECD)可以在大脑的小血管中招募和隔离功能重要的蛋白质。我们使用来自 CADASIL 患者的大脑和动脉组织以及分别在疾病的晚期和早期表现出血管病变的 CADASIL 小鼠模型进行了生化、纳米液相色谱-串联质谱和免疫组织化学分析。大脑和动脉样本的生化分级分离表明,突变型 Notch3(ECD)在小鼠和 CADASIL 患者中积累在二硫键交联的去污剂不溶性聚集体中。进一步的蛋白质组学和免疫组织化学分析鉴定了两种功能重要的细胞外基质蛋白,金属蛋白酶组织抑制剂 3(TIMP3)和纤连蛋白(VTN),它们被隔离到 Notch3(ECD) 包含的聚集体中。使用培养的细胞,我们表明 Notch3 水平的增加或聚集增强了 Notch3(ECD)-TIMP3 复合物的形成,促进了 TIMP3 的募集和积累。反过来,TIMP3 促进包括 NOTCH3 和 VTN 的复合物形成。在体内,来自 CADASIL 患者和小鼠的脑血管表现出可溶性和不溶性交联 TIMP3 物种的水平升高。此外,逆转酶谱测定显示来自 CADASIL 患者和小鼠的脑血管中 TIMP3 活性显著升高。总的来说,我们的发现支持 CADASIL 疾病病理学中的 Notch3(ECD)级联假说,该假说认为 Notch3(ECD)在脑血管中的聚集/积累是一个中心事件,促进了功能重要的细胞外基质蛋白的异常募集,这可能最终导致多因素毒性。具体来说,我们的结果表明 TIMP3 活性的失调,通过损害小血管中的细胞外基质稳态,可能导致突变型 Notch3(ECD)毒性。